Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Envoy Medical (COCH) Operating Expenses (2022 - 2025)

Envoy Medical's Operating Expenses history spans 4 years, with the latest figure at $5.8 million for Q3 2025.

  • For Q3 2025, Operating Expenses rose 14.89% year-over-year to $5.8 million; the TTM value through Sep 2025 reached $16.1 million, down 25.98%, while the annual FY2023 figure was $18.7 million, 108.82% up from the prior year.
  • Operating Expenses for Q3 2025 was $5.8 million at Envoy Medical, up from $5.1 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $6.8 million in Q4 2023 and bottomed at $901356.0 in Q2 2022.
  • The 4-year median for Operating Expenses is $4.7 million (2023), against an average of $4.1 million.
  • The largest annual shift saw Operating Expenses soared 404.02% in 2023 before it rose 4.25% in 2025.
  • A 4-year view of Operating Expenses shows it stood at $2.9 million in 2022, then skyrocketed by 133.01% to $6.8 million in 2023, then fell by 26.59% to $5.0 million in 2024, then grew by 14.89% to $5.8 million in 2025.
  • Per Business Quant, the three most recent readings for COCH's Operating Expenses are $5.8 million (Q3 2025), $5.1 million (Q2 2025), and $5.2 million (Q1 2025).